A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

This study has been completed.
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01255098
First received: December 3, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
  Purpose

This plan is to develop blood culture or to measure diagnostics of Immuno Magnetic Reduction assay in the first stage.


Condition
Immuno Magnetic Reduction

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

Further study details as provided by Taipei Medical University WanFang Hospital:

Enrollment: 300
Study Start Date: November 2009
Study Completion Date: November 2010
Groups/Cohorts
Experimental Group
Control Group

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

emergency cases

Criteria

Inclusion Criteria:

  • emergency cases
  • blood culture of positive and negative cases which storage in 4℃ every day

Exclusion Criteria:

  • not emergency cases of blood culture
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01255098

Locations
Taiwan
Taipei Medical University WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Giueng-Chueng Wang Taipei Medical University WanFang Hospital
  More Information

No publications provided

Responsible Party: Giueng-Chueng Wang, Laboratory Medicine
ClinicalTrials.gov Identifier: NCT01255098     History of Changes
Other Study ID Numbers: 98085
Study First Received: December 3, 2010
Last Updated: December 3, 2010
Health Authority: Taiwan: Department of Health

ClinicalTrials.gov processed this record on October 23, 2014